ConductScience.org, home

Trial · NCT00702234

Adverse events298

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
seriousAnaemiaBlood and lymphatic system disordersExpectant Mothers - Corifollitropin Alfa 150 µg12681
seriousAnaemiaBlood and lymphatic system disordersFetuses Present at 10 Weeks After Fresh ET in Base Study03150
seriousAnaemia neonatalBlood and lymphatic system disordersExpectant Mothers - Corifollitropin Alfa 150 µg02680
seriousAnaemia neonatalBlood and lymphatic system disordersFetuses Present at 10 Weeks After Fresh ET in Base Study33153
seriousDisseminated intravascular coagulation in newbornBlood and lymphatic system disordersExpectant Mothers - Corifollitropin Alfa 150 µg02680
seriousDisseminated intravascular coagulation in newbornBlood and lymphatic system disordersFetuses Present at 10 Weeks After Fresh ET in Base Study13151
seriousBradycardia foetalCardiac disordersExpectant Mothers - Corifollitropin Alfa 150 µg12681
seriousBradycardia foetalCardiac disordersFetuses Present at 10 Weeks After Fresh ET in Base Study13151
seriousBradycardia neonatalCardiac disordersExpectant Mothers - Corifollitropin Alfa 150 µg02680
seriousBradycardia neonatalCardiac disordersFetuses Present at 10 Weeks After Fresh ET in Base Study13151
seriousCardio-respiratory arrest neonatalCardiac disordersExpectant Mothers - Corifollitropin Alfa 150 µg02680
seriousCardio-respiratory arrest neonatalCardiac disordersFetuses Present at 10 Weeks After Fresh ET in Base Study13151
seriousFoetal heart rate disorderCardiac disordersExpectant Mothers - Corifollitropin Alfa 150 µg12681
seriousFoetal heart rate disorderCardiac disordersFetuses Present at 10 Weeks After Fresh ET in Base Study03150
seriousVentricular hypokinesiaCardiac disordersExpectant Mothers - Corifollitropin Alfa 150 µg02680
seriousVentricular hypokinesiaCardiac disordersFetuses Present at 10 Weeks After Fresh ET in Base Study13151
seriousAnal atresiaCongenital, familial and genetic disordersExpectant Mothers - Corifollitropin Alfa 150 µg02680
seriousAnal atresiaCongenital, familial and genetic disordersFetuses Present at 10 Weeks After Fresh ET in Base Study23152
seriousAnkyloglossia congenitalCongenital, familial and genetic disordersExpectant Mothers - Corifollitropin Alfa 150 µg02680
seriousAnkyloglossia congenitalCongenital, familial and genetic disordersFetuses Present at 10 Weeks After Fresh ET in Base Study13151

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00702234/events